Quantification of cidofovir in human serum by LC-MS/MS for children

被引:9
作者
Breddernann, Andre [1 ]
Hsien, Linda [1 ]
Tot, Edith [1 ]
Laeer, Stephanie [1 ]
机构
[1] Univ Dusseldorf, Dept Clin Pharm & Pharmacotherapy, D-40225 Dusseldorf, Germany
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2008年 / 861卷 / 01期
关键词
cidofovir; PMEG; LC-MS/MS; pharmacokinetic study; children;
D O I
10.1016/j.jchromb.2007.11.029
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A new method for the quantification of cidofovir (CDV), an acyclic nucleotide analogue of cytosine with antiviral activity against a broad-spectrum of DNA viruses, in human serum, using high-performance liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) has been developed. A strong anion exchange (SAX) solid-phase extraction procedure was applied for the sample preparation. The tandem mass spectrometer was tuned in the multiple reaction monitoring mode to monitor the m/z 278.1 -> 234.9 and the m/z 288.1 -> 133.1 transitions for CDV and the internal standard 9-(2-phosphonylmethoxyethyl)guanine (PMEG), respectively, using negative electrospray ionization. The MS/MS response was linear over the concentration range from 78.125 ng/ml to 10,000 ng/ml, with a lower limit of quantification of 78.125 ng/ml. The intra- and inter-day precisions (relative standard deviation (%)) for CDV were less than 7.8% and the accuracies (% of deviation from nominal level) were within +/- 12.1% for quality controls. The novel LC-MS/MS method allowed a specific, sensitive and reliable determination of CDV in human serum and was applied to investigate the yet unknown pharmacokinetic properties of CDV in a paediatric cancer patient. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 21 条
  • [1] Ion suppression in mass spectrometry
    Annesley, TM
    [J]. CLINICAL CHEMISTRY, 2003, 49 (07) : 1041 - 1044
  • [2] Separation methods for antiviral phosphorus-containing drugs
    Ba, BB
    Saux, MC
    [J]. JOURNAL OF CHROMATOGRAPHY B, 2001, 764 (1-2): : 349 - 362
  • [3] Bonfiglio R, 1999, RAPID COMMUN MASS SP, V13, P1175, DOI 10.1002/(SICI)1097-0231(19990630)13:12<1175::AID-RCM639>3.0.CO
  • [4] 2-0
  • [5] Breddemann Andre, 2007, Herpes, V14, P41
  • [6] Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis
    Brody, SR
    Humphreys, MH
    Gambertoglio, JG
    Schoenfeld, P
    Cundy, KC
    Aweeka, FT
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (01) : 21 - 28
  • [7] CLINICAL PHARMACOKINETICS OF CIDOFOVIR IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS
    CUNDY, KC
    PETTY, BG
    FLAHERTY, J
    FISHER, PE
    POLIS, MA
    WACHSMAN, M
    LIETMAN, PS
    LALEZARI, JP
    HITCHCOCK, MJM
    JAFFE, HS
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) : 1247 - 1252
  • [8] Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir
    Cundy, KC
    [J]. CLINICAL PHARMACOKINETICS, 1999, 36 (02) : 127 - 143
  • [9] High-performance liquid chromatographic determination of cytosine-containing compounds by precolumn fluorescence derivatization with phenacyl bromide: Application to antiviral nucleosides and nucleotides
    Eisenberg, EJ
    Cundy, KC
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1996, 679 (1-2): : 119 - 127
  • [10] Eksborg Staffan, 2003, Herpes, V10, P66